39mon MSN
York biotech-firm ends 2025 on high
The York-based Aptamer Group says it ends 2025 with strong momentum as global pharma partnerships drive confidence for 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback